Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 187
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Danish Synthetic Biology Drug Developer Octarine and British Clinical Research Organisation...
CB Therapeutics granted a new patent that will help further provide...
Wake Network, Inc. Receives Certificate of Drug Registration for Microdose Formulation...
Core One Labs’ Upgrades to OTCQB Venture Market
Algernon Pharmaceuticals Announces Issuance of Patent for Ifenprodil for the Treatment...
Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to...
Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million...
HAVN Life To Be Featured On Viewpoint with Dennis Quaid
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health...
Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright &...
Load more